NO20031259L - Metode for å hindre og/eller behandle infeksjoner - Google Patents

Metode for å hindre og/eller behandle infeksjoner

Info

Publication number: NO20031259L
Authority: NO; Norway
Prior art keywords: dietary fiber; humans; inhibition; prevention; dietary
Prior art date: 2000-09-28

Application number

NO20031259A

Other languages

English (en)

Other versions

NO20031259D0 (no

NO331751B1 (no

Inventor

Randal K Buddington

Jan Van Loo

Anne Frippiat

Original Assignee

Tiense Suikerraffinaderij Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-28

Filing date

2003-03-19

Publication date

2003-05-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24693153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031259(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-03-19 Application filed by Tiense Suikerraffinaderij Nv filed Critical Tiense Suikerraffinaderij Nv

2003-03-19 Publication of NO20031259D0 publication Critical patent/NO20031259D0/no

2003-05-07 Publication of NO20031259L publication Critical patent/NO20031259L/no

2012-03-19 Publication of NO331751B1 publication Critical patent/NO331751B1/no

Links

208000015181 infectious disease Diseases 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
235000013325 dietary fiber Nutrition 0.000 abstract 5
239000000203 mixture Substances 0.000 abstract 4
229920001202 Inulin Polymers 0.000 abstract 2
241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
244000052616 bacterial pathogen Species 0.000 abstract 2
230000005764 inhibitory process Effects 0.000 abstract 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
229940029339 inulin Drugs 0.000 abstract 2
230000002265 prevention Effects 0.000 abstract 2
230000009885 systemic effect Effects 0.000 abstract 2
241000723343 Cichorium Species 0.000 abstract 1
235000007542 Cichorium intybus Nutrition 0.000 abstract 1
229920002670 Fructan Polymers 0.000 abstract 1
235000013376 functional food Nutrition 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000006116 polymerization reaction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Botany (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fodder In General (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20031259A 2000-09-28 2003-03-19 Bruk av kostfiber eller en blanding av kostfiber for fremstilling av en blanding for oral administrasjon for behandling av systeminfeksjoner hos fisk. NO331751B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/671,106 US7431939B1 (en)	2000-09-28	2000-09-28	Inhibition of systemic infections in humans and vertebrates by dietary fibers
PCT/EP2001/011198 WO2002026242A2 (en)	2000-09-28	2001-09-27	Inhibition of systemic infections in humans and vertebrates by dietary fibers

Publications (3)

Publication Number	Publication Date
NO20031259D0 NO20031259D0 (no)	2003-03-19
NO20031259L true NO20031259L (no)	2003-05-07
NO331751B1 NO331751B1 (no)	2012-03-19

Family

ID=24693153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031259A NO331751B1 (no)	2000-09-28	2003-03-19	Bruk av kostfiber eller en blanding av kostfiber for fremstilling av en blanding for oral administrasjon for behandling av systeminfeksjoner hos fisk.

Country Status (11)

Country	Link
US (1)	US7431939B1 (no)
EP (1)	EP1320375B1 (no)
JP (1)	JP4309650B2 (no)
CN (1)	CN1315482C (no)
AT (1)	ATE315399T1 (no)
CA (1)	CA2423783C (no)
DE (1)	DE60116662T2 (no)
DK (1)	DK1320375T3 (no)
ES (1)	ES2252317T3 (no)
NO (1)	NO331751B1 (no)
WO (1)	WO2002026242A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7431939B1 (en)	2000-09-28	2008-10-07	Mississippi State University	Inhibition of systemic infections in humans and vertebrates by dietary fibers
US20040001898A1 (en) *	2002-06-26	2004-01-01	Armand Malnoe	Compositions and methods for detoxification and cancer prevention
ZA200805905B (en)	2005-12-16	2009-10-28	Nutricia Nv	Use of soluble dietary fibres against muscle wasting
US20100316769A1 (en) *	2006-03-29	2010-12-16	Gail Czarnecki-Maulden	Dietary supplements containing probiotics
US20090061008A1 (en) *	2007-08-30	2009-03-05	Levy Mark M	Fiber/granule complex for treatment of the gi tract
SI2285387T1 (sl)	2008-06-13	2016-02-29	N.V. Nutricia	Prehrana za preprečevanje infekcij
CN103025307B (zh) *	2010-06-30	2017-03-29	雀巢产品技术援助有限公司	菊苣酸及衍生物用于调节皮肤色素沉着的用途
ES2738632T3 (es)	2012-02-16	2020-01-24	Akeso Biomedical Inc	Complejos de hierro para la reducción de la colonización del tracto gastrointestinal por Campylobacter
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
EP3079502A1 (en)	2013-11-04	2016-10-19	N.V. Nutricia	Fermented formula with non digestible oligosaccharides
CA2957790A1 (en) *	2014-08-13	2016-02-18	Akeso Biomedical, Inc.	Antimicrobial compounds and compositions, and uses thereof
RU2721257C2 (ru) *	2015-06-23	2020-05-18	Сосьете Де Продюи Нестле С.А.	Питательные композиции и детские смеси, содержащие олигофруктозу, для снижения нагрузки патогенных бактерий в кишечнике младенцев и детей младшего возраста
CN104872457A (zh) *	2015-06-23	2015-09-02	通威股份有限公司	一种提高罗非鱼抗链球菌能力的配合饲料
JP6637587B2 (ja) *	2015-08-04	2020-01-29	ズートツッカーアーゲー	副鼻腔炎に対するイヌリンの予防的使用
US10653658B2 (en)	2015-08-11	2020-05-19	Akeso Biomedical, Inc.	Biofilm inhibiting compositions enhancing weight gain in livestock
DK3334440T3 (en)	2015-08-11	2021-07-26	Akeso Biomedical Inc	Biofilm inhibiting compositions enhancing weight gain in livestock
CN105124248A (zh) *	2015-08-28	2015-12-09	通威股份有限公司	一种提高红罗非鱼抗病机能的配合饲料
EP3207933A1 (en) *	2016-02-17	2017-08-23	Proponent Biotech GmbH	Uses of polyfructans
BE1025705B1 (fr) *	2017-09-12	2019-06-18	Cosucra Groupe Warcoing Sa	Amélioration de la maladie et des conditions générales de la volaille et du bétail à l'aide d'une racine chicorée séchée
US10842811B2 (en) *	2018-02-28	2020-11-24	The Trustees Of Columbia University In The City Of New York	Inulin for preventing antibiotic resistant infection and pathogen colonization
CN120514728B (zh) *	2025-06-30	2026-03-10	湖南师范大学	菊糖在提高氨苄青霉素对耐药沙门氏菌作用效率中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3689071T2 (de) *	1985-10-31	1994-02-10	Univ Australian	Immunheilbehandlung.
US5032579A (en)	1987-10-13	1991-07-16	Coors Biotech, Inc.	Method for inhibiting the growth of salmonella
EP0483070B1 (en)	1990-10-24	1995-04-12	Novartis Nutrition AG	Nutritionally complete feeding composition containing hydrolysed soluble fiber
ES2060543B1 (es) *	1993-03-26	1995-04-01	Cia Gral Del Algarrobo De Espa	Fibra natural de algarroba y procedimiento para su obtencion.
EP0792889B1 (de)	1993-08-10	2000-12-27	Südzucker Aktiengesellschaft Mannheim/Ochsenfurt	Verwendung von Inulinderivaten
US6001878A (en)	1994-01-11	1999-12-14	Van Leeuwen; Paulus Aloisius Marie	Method of treating disorders of the animal or human body by administering amino acids
US6241983B1 (en) *	1994-10-28	2001-06-05	Metagenics, Inc.	Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
DE69506095T2 (de) *	1995-08-04	1999-06-24	Naamloze Vennootschap Nutricia, Zoetermeer	Diätfasern enthaltende Nahrungszusammensetzung
EP0879600A1 (en) *	1997-05-20	1998-11-25	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Fructan containing composition for the prevention and treatment of colon cancer
ES2221014T3 (es)	1997-06-23	2004-12-16	Societe Des Produits Nestle S.A.	Composicion nutritiva que contiene fibras de guisante e inulina.
EP0904784A1 (en)	1997-09-22	1999-03-31	N.V. Nutricia	Probiotic nutritional preparation
US6248375B1 (en) *	2000-03-14	2001-06-19	Abbott Laboratories	Diabetic nutritionals and method of using
US7431939B1 (en)	2000-09-28	2008-10-07	Mississippi State University	Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1428528A1 (en)	2002-09-27	2004-06-16	Tiense Suikerraffinaderij N.V.	Synergistic combinations of dietary fiber and NSAIDs for the treatment of cancer

2000
- 2000-09-28 US US09/671,106 patent/US7431939B1/en not_active Expired - Lifetime
2001
- 2001-09-27 CN CNB018165524A patent/CN1315482C/zh not_active Expired - Fee Related
- 2001-09-27 EP EP01985674A patent/EP1320375B1/en not_active Revoked
- 2001-09-27 AT AT01985674T patent/ATE315399T1/de not_active IP Right Cessation
- 2001-09-27 CA CA002423783A patent/CA2423783C/en not_active Expired - Fee Related
- 2001-09-27 JP JP2002530072A patent/JP4309650B2/ja not_active Expired - Fee Related
- 2001-09-27 DK DK01985674T patent/DK1320375T3/da active
- 2001-09-27 ES ES01985674T patent/ES2252317T3/es not_active Expired - Lifetime
- 2001-09-27 DE DE60116662T patent/DE60116662T2/de not_active Expired - Lifetime
- 2001-09-27 WO PCT/EP2001/011198 patent/WO2002026242A2/en not_active Ceased
2003
- 2003-03-19 NO NO20031259A patent/NO331751B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2423783C (en)	2007-11-20
NO20031259D0 (no)	2003-03-19
DE60116662D1 (de)	2006-04-06
US7431939B1 (en)	2008-10-07
ES2252317T3 (es)	2006-05-16
JP2004509922A (ja)	2004-04-02
JP4309650B2 (ja)	2009-08-05
NO331751B1 (no)	2012-03-19
DE60116662T2 (de)	2006-11-09
EP1320375A2 (en)	2003-06-25
DK1320375T3 (da)	2006-05-22
WO2002026242A2 (en)	2002-04-04
ATE315399T1 (de)	2006-02-15
CA2423783A1 (en)	2002-04-04
CN1466460A (zh)	2004-01-07
EP1320375B1 (en)	2006-01-11
CN1315482C (zh)	2007-05-16
WO2002026242A3 (en)	2002-05-30

Legal Events

Date	Code	Title	Description
2019-04-29	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20031259D0 (no)	2003-03-19	Metode for å hindre og/eller behandle infeksjoner
UA89791C2 (ru)	2010-03-10	Пищевая композиция, которая содержит неусваиваемые олигосахариды, для лечения или профилактики инфекций респираторного тракта
UA27848C2 (uk)	2000-10-16	Лікарська форма, що перорально вводиться, для лікування центральних станів дефіциту допаміну
DE60128395D1 (de)	2007-06-21	Ernährungszusammensetzung mit gesundheitsfördernder wirkung enthaltend oligosaccharide
ATE326862T1 (de)	2006-06-15	Oligosaccharide enthaltende ernährungszusammensetzungen
BG104680A (en)	2001-02-28	Celecoxib compositions
CA2400244A1 (en)	2001-08-23	Antiadhesive carbohydrates comprising a terminal uronic acid unit containing a carbon-carbon double bond
DE69818707D1 (de)	2003-11-06	Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
JP2004509922A5 (no)	2005-04-28
BR0008059A (pt)	2002-03-26	Composições de valdecoxib
KR950007868A (ko)	1995-04-15	항궤양제 및 헬리코박터·피롤리의 정착저해제
ZA200805905B (en)	2009-10-28	Use of soluble dietary fibres against muscle wasting
CA2507926A1 (en)	2003-04-03	Pharmaceutical composition comprising chito-oligomers
EA200802038A1 (ru)	2009-06-30	Фармацевтическая композиция энтеросорбента и пребиотиков, лекарственные формы и способ профилактики и лечения заболеваний желудочно-кишечного тракта
ATE289803T1 (de)	2005-03-15	Pharmazeutische aerosolformulierung
PT866791E (pt)	2002-05-31	Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
BR9911962A (pt)	2001-03-27	Composição oral que apresenta eficiência antiplaca aumentada, e, processo para o tratamento e prevenção do acúmulo de placa bacteriana nos dentes.
BR0115112A (pt)	2003-09-30	Polissacarìdeo extracelular bacteriano, cepa de gluco nacetobacter spp. que produz o mesmo e seu uso em produtos alimentìcios e produtos alimentìcios para animais de estimação
KR920011469A (ko)	1992-07-24	구강 조성물
Bugorkova	1999	Comparative characterization of the pathogenic action of Vibrio cholerae of group non-O 1, serovar O 139, and group O 1 on the APUD system of the intestine of suckling rabbits
KR920021160A (ko)	1992-12-18	알긴 산소다를 주제로한 위장관질환치료제에 대한 개량 및 그의 제조방법
KR960700053A (ko)	1996-01-19	방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
AU2001295839A1 (en)	2002-05-15	Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
TH36959A (th)	2000-01-24	มาโครไลต์ชนิดใหม่
FI20011402A7 (fi)	2002-12-30	Lääkkeet ja hoitotavat patogeenejä vastaan